Where We Serve/New Jersey
State guide

Psychedelic Therapy in New Jersey

Last reviewed · June 20, 2026

New Jersey has not broadly legalized psilocybin. In January 2026 the state enacted a limited psilocybin therapy pilot program, though it is narrow and not yet operational. Ketamine and esketamine are available in clinical settings across the state.

A quiet Pine Barrens stream at dawn, soft golden light, a calm landscape evoking readiness for psychedelic therapy in New Jersey.
How to access care

Your paths to care in New Jersey.

1
Legal in New Jersey.

Ketamine in medical settings, and esketamine (Spravato) at REMS-certified clinics. A 2026 law created a limited psilocybin therapy pilot that is not yet operational.

2
Legal out of state.

Licensed psilocybin services in Oregon and regulated natural medicine in Colorado.

3
Underground or ceremonial.

These options exist and carry legal risk. We do not broker illegal activity. Our concierge supports education, safety, and integration.

Your access options

Compare the routes, side by side.

Pathway
What it looks like
Key notes
Ketamine or Esketamine (in New Jersey)
Medical screening, monitored sessions, integration support recommended.
Esketamine (Spravato) is FDA-approved for treatment-resistant depression at REMS-certified sites. Most mental-health ketamine uses are off-label.
Psilocybin services (Oregon)
Licensed service centers statewide, with preparation, administration, and integration.
See our Oregon guide for how access works.
Natural Medicine services (Colorado)
Licensed Healing Centers and facilitators under state rules.
See our Colorado guide; always verify licensing on state sites.
MDMA-assisted therapy
Not FDA-approved as of 2026. Access primarily via clinical trials.
The FDA issued a Complete Response Letter and requested an additional Phase 3 trial.
Underground or ceremonial
Community or private settings. Laws and safety practices vary by location.
We do not broker or endorse illegal activity. Our concierge provides education, vetting criteria, and integration support.
Not sure which path fits you?

We help you choose clear-eyed.

Our concierge compares legal routes, explains the rules in plain language, and helps you choose a path that matches your needs, values, and safety profile.

The landscape

Psychedelic care in New Jersey.

New Jersey took a real step in January 2026, when the governor signed a law creating a psilocybin behavioral health therapy pilot program with a six million dollar appropriation. The enacted version was scaled back from earlier proposals that would have decriminalized personal use. It is narrow and evaluative, designed to study therapeutic access rather than open broad or commercial availability, and it is not yet operational. Psilocybin otherwise remains illegal, though a 2021 law reduced the penalty for possessing small amounts.

While that program develops, most people in New Jersey access care through medical ketamine and esketamine, or by traveling to licensed psilocybin services in Oregon or regulated options in Colorado. Our concierge helps you compare these routes, understand the legal picture, review medical and psychological safety, and plan preparation and integration so you are not navigating it alone.

Costs & logistics

What to budget for.

Ketamine and esketamine: total cost depends on format, the number of sessions, supervision, and integration. IV ketamine commonly runs several hundred dollars per session, with a starting course of multiple sessions. Esketamine (Spravato) is often covered by insurance for treatment-resistant depression because it is FDA-approved, while IV and IM ketamine for mental health are usually off-label and paid out of pocket.

Psilocybin services in Oregon or Colorado: licensed centers set their own session pricing, which usually includes preparation and integration. Add travel and lodging. Verify licensing on the state program sites before you book.

Ask about HSA or FSA eligibility where applicable. Coverage and policies vary by plan and provider.

Safety & screening

Before any session, cover this.

  • Share all medications, especially SSRIs and SNRIs, MAOIs, stimulants, and blood-pressure drugs.
  • Review cardiac history, seizure risk, bipolar spectrum, psychosis risk, pregnancy, and sleep apnea.
  • Confirm monitoring, chaperone policies, and emergency planning with any provider.
  • If considering at-home or compounded ketamine, discuss supervision and current FDA alerts with your prescriber.

Learn more about our Safety and Harm Reduction principles.

Our role

What we do, and what we don’t.

What we do

  • Education, safety screening guidance, and integration support
  • Compare legal options and verify licensed programs
  • Share the vetting questions we ask any facilitator

What we do not do

  • Sell, supply, or store controlled substances
  • Instruct on obtaining substances or connect to distributors
  • Provide medical or legal advice
Cultural & legal context

A closer look at New Jersey.

A new therapy pilot

In January 2026 New Jersey enacted a psilocybin behavioral health pilot program with a six million dollar appropriation. It was scaled back from broader proposals, is evaluative in purpose, and is not yet operational. It is a first step, not open access.

A deep clinical market

New Jersey sits between the New York City and Philadelphia markets, with ketamine and esketamine widely available. Quality and approach vary, which is exactly where vetting matters.

Care today: what people actually do

Most seekers here pursue medical ketamine or esketamine with screening and monitoring, or travel to licensed psilocybin services in Oregon or Colorado. Underground and ceremonial work also exists and carries legal and safety risk. We do not broker illegal activity. We help you compare options and plan safely.

Why this matters

New Jersey is moving carefully toward therapeutic access while the federal picture evolves. The focus stays on safety, informed consent, and integration. If you are exploring this path, our concierge can help you choose a route that fits your goals, values, and risk profile.

New Jersey FAQ

Questions, answered plainly.

Is psilocybin therapy legal in New Jersey?+
Not broadly.

Psilocybin is not broadly legal in New Jersey. In January 2026 the state enacted a limited psilocybin therapy pilot program, but it is narrow, evaluative, and not yet operational. General possession remains illegal, though a 2021 law reduced penalties for small amounts.

What legal options are in New Jersey today?+
Ketamine and esketamine.

Medical ketamine (IV or IM, off-label) and esketamine (Spravato) at REMS-certified clinics are legal and available. For psilocybin, the legal route is to travel to licensed services in Oregon or Colorado.

Will the new pilot give me access soon?+
Not yet.

The 2026 pilot is a first step focused on study and limited therapeutic access. It is not an open program and is not operational yet. We will update this page as it develops.

Can I travel for legal psilocybin services?+
Yes.

Many people from New Jersey travel to Oregon or Colorado, where supervised psilocybin or natural medicine services are licensed and regulated. Our concierge can help you understand how access works and plan preparation and integration.

Is MDMA-assisted therapy available?+
Not yet, outside trials.

MDMA-assisted therapy is not FDA-approved. The FDA issued a Complete Response Letter and requested an additional Phase 3 trial. Access is primarily through clinical trials.

How much does ketamine therapy cost in New Jersey?+
It varies.

IV ketamine commonly runs several hundred dollars per session, with a starting course of multiple sessions. Esketamine (Spravato) is often insurance-covered for treatment-resistant depression because it is FDA-approved. See our pricing page for our concierge fees, which are separate from any provider's charges.

What should I ask a clinic or facilitator before booking?+
Screening, monitoring, integration.

Ask about medical and psychological screening, who monitors you during sessions, emergency planning, and what preparation and integration are included. These are the questions we ask any provider before we match you.

Are there medical or medication contraindications?+
Yes, several.

Share all medications, especially SSRIs and SNRIs, MAOIs, stimulants, and blood-pressure drugs, and review cardiac history, seizure risk, bipolar spectrum, psychosis risk, pregnancy, and sleep apnea with a qualified provider. This is general information, not medical advice.

Next steps

Need help choosing? Let’s talk.

Our concierge can walk you through the legal options in your area, with no pressure and no sales pitch.

← Explore another state or city